IL6 and chronic obstructive pulmonary disease: Although the mechanisms explaining the relationship between respiratory impairment and diabetes remain unclear, Lin et al. suggested that systemic inflammation could be a plausible explanation.13 In patients with COPD, the levels of inflammatory mediators (such as tumour necrosis factor alpha, interleukin-6 or C-reactive protein) were showed to be increased.